Karyopharm Therapeutics (NASDAQ:KPTI) is set to give its latest quarterly earnings report on Thursday, 2024-02-29. Here’s what investors need to know before the announcement.
Analysts estimate that Karyopharm Therapeutics will report an earnings per share (EPS) of $-0.31.
Karyopharm Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …